Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of the Crohn's disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary.
Higgins PDR, Harding G, Leidy NK, DeBusk K, Patrick DL, Viswanathan HN, Fitzgerald K, Donelson SM, Cyrille M, Ortmeier BG, Wilson H, Revicki DA, Globe G. Higgins PDR, et al. Among authors: fitzgerald k. J Patient Rep Outcomes. 2017;2(1):24. doi: 10.1186/s41687-018-0044-7. Epub 2018 May 9. J Patient Rep Outcomes. 2017. PMID: 29770803 Free PMC article.
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary.
Higgins PDR, Harding G, Revicki DA, Globe G, Patrick DL, Fitzgerald K, Viswanathan H, Donelson SM, Ortmeier BG, Chen WH, Leidy NK, DeBusk K. Higgins PDR, et al. Among authors: fitzgerald k. J Patient Rep Outcomes. 2017;2(1):26. doi: 10.1186/s41687-018-0049-2. Epub 2018 May 30. J Patient Rep Outcomes. 2017. PMID: 29888745 Free PMC article.
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Patients with Crohn's Disease and Ulcerative Colitis.
Loftus EV Jr, Ananthakrishnan AN, Lee WJ, Gonzalez YS, Fitzgerald KA, Wallace K, Zhou W, Litcher-Kelly L, Ollis SB, Su S, Danese S. Loftus EV Jr, et al. Among authors: fitzgerald ka. Pharmacoecon Open. 2023 Sep;7(5):823-840. doi: 10.1007/s41669-023-00419-w. Epub 2023 Jun 9. Pharmacoecon Open. 2023. PMID: 37296268 Free PMC article.
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease.
Louis E, Lee WJ, Litcher-Kelly L, Ollis S, Pranschke E, Fitzgerald K, Lacerda AP, Neimark E, Sanchez Gonzalez Y, Panés J. Louis E, et al. Among authors: fitzgerald k. Adv Ther. 2024 Sep;41(9):3678-3705. doi: 10.1007/s12325-024-02923-9. Epub 2024 Aug 6. Adv Ther. 2024. PMID: 39105965 Free PMC article.
Development of a new patient-reported outcome measure in sarcopenia.
Evans CJ, Chiou CF, Fitzgerald KA, Evans WJ, Ferrell BR, Dale W, Fried LP, Gandra SR, Dennee-Sommers B, Patrick DL. Evans CJ, et al. J Am Med Dir Assoc. 2011 Mar;12(3):226-33. doi: 10.1016/j.jamda.2010.09.010. Epub 2010 Nov 25. J Am Med Dir Assoc. 2011. PMID: 21333926
Assessing the Uptake of the Lung Cancer Core Outcome Set: A Cross-Sectional Analysis.
Tran AV, Dennis B, Rashid M, Fitzgerald K, Jones G, Magana K, Modi J, Magee T, Ward S, Hughes G, Ford AI, Vassar M. Tran AV, et al. Among authors: fitzgerald k. JTO Clin Res Rep. 2024 Aug 23;5(12):100713. doi: 10.1016/j.jtocrr.2024.100713. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39502497 Free PMC article.
Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair.
Jena KK, Mambu J, Boehmer D, Sposito B, Millet V, de Sousa Casal J, Muendlein HI, Spreafico R, Fenouil R, Spinelli L, Wurbel S, Riquier C, Galland F, Naquet P, Chasson L, Elkins M, Mitsialis V, Ketelut-Carneiro N, Gwilt KB, Thiagarajah JR, Ruan HB, Lin Z, Lien E, Shao F, Chou J, Poltorak A, Ordovas-Montanes J, Fitzgerald KA, Snapper SB, Broggi A, Zanoni I. Jena KK, et al. Among authors: fitzgerald ka. Cell. 2024 Oct 30:S0092-8674(24)01158-9. doi: 10.1016/j.cell.2024.10.010. Online ahead of print. Cell. 2024. PMID: 39500322
Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System.
Moazami MP, Rembetsy-Brown JM, Sarli SL, McEachern HR, Wang F, Ohara M, Wagh A, Kelly K, Krishnamurthy PM, Weiss A, Marosfoi M, King RM, Motwani M, Gray-Edwards H, Fitzgerald KA, Brown RH, Watts JK. Moazami MP, et al. Among authors: fitzgerald ka. Mol Ther. 2024 Oct 25:S1525-0016(24)00684-1. doi: 10.1016/j.ymthe.2024.10.024. Online ahead of print. Mol Ther. 2024. PMID: 39460376 Free article.
1,291 results